Search results for: 'new'
- Related search terms
- new growth opportunities in the headsets market in latin america
- New Zealand Contact Center Applications Market
- new tech market presence segments dots mitigation
- new tech market presence segments duti mitigation
- new tech market presence segments ddos mitigation
-
15 Nov 2011  |  North America  |  Market Research
Vital Signs - Healthcare News - The Analyst's Perspective (TAP)
This issue of Vital Signs, released on November 15, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, Patient Monitoring, and Lifescience Tools.
$1,500.00
Special Price $1,125.00 save 25 %
-
22 Nov 2019  |  North America  |  Market Research
News Alert—US-China Tariff War Implication for Healthcare Industry
Better Understand the Timeline of the Tariff War and What Triggered the Hostilities
As the US-China Tariff War continues to escalate, the Transformational Healthcare Team at global research firm Frost & Sullivan has made available an insight analysis exploring the threats and opportunities for US businesses in China. The insight analysis also examines the timeline and causes of the tariff war and explores why medical technology (M...
$1,500.00
Special Price $1,125.00 save 25 %
-
02 May 2011  |  North America  |  Market Research
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented ...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2020  |  North America  |  Market Research
New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025
AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities
Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  North America  |  Market Research
Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities
In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Jun 2019  |  North America  |  Technology Research
Internet-delivered Therapies and Mobile Health Ushering a New Health Paradigm
Redefining the Future of Healthcare by Providing Remote, Timely, Patient-Specific Healthcare Interventions
The mobile and wireless technologies have revolutionized the healthcare service delivery across the globe. Mobile and Internet based healthcare therapies and services in form of patient monitoring devices or personal digital assistants provide great connectivity and convenience. This research service (RS) showcases the innovations in digital and mo...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Jul 2020  |  North America  |  Market Research
Post-pandemic Global Healthcare Market Outlook, 2020
Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’
Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 Mar 2021  |  North America  |  Market Outlook
Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021
Digital Transformation Leads to New Growth Strategies for Stakeholders
The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the years events, healthcare delivery has accelerated its transformatio...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Nov 2019  |  North America  |  Market Research
Analysis of the Hospital Asset Management Market, Forecast to 2023
Integration and Interoperability would Drive New Opportunities
A critical aspect of efficiency in healthcare organizations is asset management. Hospitals have thousands of assets to track and maintain, and failure of which results in increased waste and downtime, restricted patient flow, decreased quality of care, poor employee productivity, and financial losses. Hospitals are demanding more holistic solution...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jul 2021  |  North America  |  Market Research
US Digital Therapeutics Growth Opportunities
Transformational Growth in New Business Models After COVID-19
Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...
$4,950.00
Special Price $3,712.50 save 25 %